STOCK TITAN

Biofrontera Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Biofrontera Inc. (NASDAQ:BFRI) has announced that it will release its fourth quarter and full-year 2022 financial results on March 8, 2023, after the market close. A conference call will follow at 4:30 PM ET to discuss the results. Biofrontera specializes in dermatological products, particularly photodynamic therapy and topical antibiotics for conditions like actinic keratoses and impetigo. Investors can access the conference call using a toll-free number or through a webcast provided in the press release.

Positive
  • None.
Negative
  • None.

WOBURN, MA / ACCESSWIRE / February 22, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three and 12 months ended December 31, 2022 on Wednesday, March 8, 2023. The results will be released after the market close and the company will host a conference call at 4:30PM Eastern Time.

Biofrontera Inc., Wednesday, February 22, 2023, Press release picture

Conference call:Wednesday, March 8, 2023 at 4:30PM ET
Toll Free:888-506-0062
International:973-528-0011
Access Code:990014
Webcast:https://www.webcaster4.com/Webcast/Page/2948/47545

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Biofrontera Investor Relations
ir@bfinc.com

SOURCE: Biofrontera Inc.



View source version on accesswire.com:
https://www.accesswire.com/740258/Biofrontera-Inc-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results-on-March-8-2023

FAQ

When will Biofrontera Inc. report its financial results?

Biofrontera Inc. will report its financial results for the fourth quarter and full year 2022 on March 8, 2023.

What time is the Biofrontera Inc. conference call?

The conference call for Biofrontera Inc. will take place at 4:30 PM ET on March 8, 2023.

How can I access the Biofrontera Inc. financial results call?

You can access the call via toll-free number 888-506-0062 or through the webcast link provided in the press release.

What products does Biofrontera Inc. focus on?

Biofrontera Inc. specializes in dermatological products, including photodynamic therapy and topical antibiotics.

Biofrontera Inc.

NASDAQ:BFRI

BFRI Rankings

BFRI Latest News

BFRI Stock Data

8.29M
5.84M
32.06%
20.68%
8.25%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
WOBURN